InvestorsHub Logo
Post# of 316463
Next 10
Followers 364
Posts 113767
Boards Moderated 5
Alias Born 12/28/2000

Re: cintrix post# 307185

Friday, 08/10/2018 8:48:26 AM

Friday, August 10, 2018 8:48:26 AM

Post# of 316463
GEMP taking another huge hit - down 64% - said a phase 2a trial of its treatment for non-alcoholic fatty liver disease in pediatric patients will be terminated, citing "unanticipated problems."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.